Efficacy of IV Tisuse Plasminogen Activator in Acute Stroke
Neurol 61:71-75, Hsia,A.W.,et al, 2003

Clinical Manifestations of Sarin Nerve Gas Exposure
JAMA 290:659-662, Lee,E.C., 2003

Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
Stroke 34:1923-1924, Higashida,R.T.,et al, 2003

Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003

Intra-arterial Thrombolysis in 24 Consecutive Patients with Internal Carotid Artery T Occlusions
JNNP 74:739-742, Arnold,M.,et al, 2003

Headache and Confusion: the Dangers of a Raw Snail Supper
Lancet 361:1866, Chau,T.T.H.,et al, 2003

Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003

Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy
Stroke 34:e55, Lattimore,S.U.,et al, 2003

Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue
Stroke 34:1425-1430, Shih,L.C.,et al, 2003

Major Risk Factors for Aneurysmal Subarrachnoid Hemorrhage in the Young are Modifiable
Stroke 34:1375-1381, Broderick,J.P.,et al, 2003

Arterial Thrombosis Induced by IVIg and Its Treatment with tPA
Neurol 60:1825-1826,1736, Okuda,D.,et al, 2003

Apoptosis and Caspases in Neurodegenerative Diseases
NEJM 348:1365-1375, Friedlander,R.M., 2003

Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality
Stroke 34:1106-1113, Heuschmann,P.U.,et al, 2003

Pre- and In-Hospital Delays From Stroke Onset to Intra-arterial Thrombolysis
Stroke 34:1230-1234, Nedeltchev,K.,et al, 2003

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003

Hemi-orolingual Angioedema and ACE Inhibition After Alteplase Treatment of Stroke
Neurol 60:1525-1527,1403, Hill,M.D.,et al, 2003

West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003

Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator
Stroke 34:968-974, Teernstra,O.P.M.,et al, 2003

Cuahoga County Operation Stroke Speed of Emergency Department Evaluation and Compliance with National Institutes of Neurological Disorders and Stroke Time Targets
Stroke 34:994-998, Katzan,I.L.,et al, 2003

Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003

Central Nervous System Paracoccidioidomycosis: Imaging Findings in 17 Cases
J Comput Assist Tomogr 27:12-17, Gasparetto,E.L.,et al, 2003

Alcohol Consumption and Risk of Stroke
JAMA 289:579-588, Reynolds,K.,et al, 2003

Pseudo-Subarachnoid Hemorrhage: A Potential Imaging Pitfall Associated with Diffuse Cerebral Edema
AJNR 24:254-256, Given,C.A. II,et al, 2003

Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset?
Stroke 34:464-467, Kent,D.M.,et al, 2003

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003

Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003

Bilateral Striatal Necrosis Associated with Mycoplasma pneumoniae Infection
NEJM 348:720, van Vuiren,M. &Uhl,M., 2003

Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Arch Neurol 60:203-208, Luchsinger,J.A.,et al, 2003

Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003

Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003

Sucessful Treatment of Radiation-Induced Brain Necrosis by Hyperbaric Oxygen Therapy
J Neurol Sci 209:115-117, Kohshi,K.,et al, 2003

Reversible Postictal MRI Change Mimicking Structural Lesion
Clin Neurol Neurosurg 105:288-290, Hicdonmez, T.,et al, 2003

Carbon Monoxide Poisoning and Sensorineural Hearing Loss
J Laryngol Otol 117:134-137, Hassan,M.S.,et al, 2003

Diffusion-Weighted MR Findings in Isolated Angilitis of the Central Nervous System (IACNS)
Acta Neurol Scand 108:346-351, Lee, S.-Y.,et al, 2003

Glioblastoma in Kidney Transplant Recipients. Report of Five Cases
J Neurooncol 63:33-37, Salvati,M.,et al, 2003

Serial Proton MR Spectroscopy and Diffusion Imaging Findings in HIV-Related Herpes Simplex Encephalitis
AJNR 24:2015-2019, S�mann,P.G., et al, 2003

Thalidomide-Induced Neuropathy
Neurol 59:1872-1875, Chaudhry,V.,et al, 2002

Delayed Neuropathy and Myelopathy After Organophosphate Intoxication
NEJM 347:1119-1121, Chuang,C.,et al, 2002

Statin-Associated Myopathy With Normal Creatine Kinase Levels
Ann Int Med 137:581-585,617, Phillips,P.S.,et al, 2002

Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002

Natural History of Perihematomal Edema in Patients with Hyperacute Spontaneous Intracerebral Hemorrhage
Stroke 33;2631-2635, Gebel,J.M.,et al, 2002

Relative Edema Volume Is a Predictor of Outcome in Patients With Hyperacute Spontaneous Intracerebral Hemorrhage
Stroke 33:2636-2641, Gebel,J.M.,et al, 2002

Two Patients With Unusual Forms of Varicella-Zoster Virus Vasculopathy
NEJM 347:1500-1503, Gilden,D.H.,et al, 2002

A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002

Late Secondary Ischemic Injury in Patients Receiving Intraarterial Thrombolysis
Ann Neurol 52:698-703,695, Kidwell,C.S.,et al, 2002